Alexandra P. Zorzi

A phase I study of histone deacetylase inhibitor, pracinostat (SB939), in pediatric patients with refractory solid tumors: IND203 a trial of the NCIC IND program/C17 pediatric phase I consortium

Alexandra P. Zorzi, Mark L. Bernstein, Yvan Samson et al. · Pediatric Blood & Cancer · 2013 · 48 citations

Pharmacy, Oncology, Pharmacology +17

The impact of Action Schools! BC on the health of Aboriginal children and youth living in rural and remote communities in British Columbia

Dona Tomlin, PJ Naylor, Heather McKay et al. · International Journal of Circumpolar Health · 2012 · 45 citations · Full text

Public Health, Child Health, Health Promotion +17

Genomic Microsatellite Signatures Identify Germline Mismatch Repair Deficiency and Risk of Cancer Onset

Jiil Chung, Logine Negm, Vanessa Bianchi et al. · Journal of Clinical Oncology · 2022 · 39 citations · Full text

Life Sciences, Genetics, Oncology +17

Association of Virtual Care Expansion With Environmental Sustainability and Reduced Patient Costs During the COVID-19 Pandemic in Ontario, Canada

Blayne Welk, Eric McArthur, Alexandra P. Zorzi · JAMA Network Open · 2022 · 35 citations · Full text

Public Affairs, Health Care Management, Health Sciences +17

Prevalence of impaired glucose tolerance and the components of metabolic syndrome in Canadian Tsimshian Nation youth.

Alexandra P. Zorzi, Gita Wahi, Andrew Macnab et al. · PubMed · 2009 · 29 citations

Medicine, Endocrinology, Clinical Nutrition +12